Cart
sales@molnova.com
IBET151-VHL-PROTAC
CAS No. ——
IBET151-VHL-PROTAC( —— )
Catalog No. M16950 CAS No. ——
IBET151-VHL-PROTAC is a novel PROTAC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIBET151-VHL-PROTAC
-
NoteResearch use only, not for human use.
-
Brief DescriptionIBET151-VHL-PROTAC is a novel PROTAC.
-
DescriptionIBET151-VHL-PROTAC is a novel PROTAC.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPROTAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1140.331
-
Molecular FormulaC58H69N13O10S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(2S,4R)-1-((2S)-2-(3-((1-(2-(3-((2-(7-(3,5-dimethylisoxazol-4-yl)-8-methoxy-2-oxo-1-((R)-1-(pyridin-2-yl)ethyl)-1Himidazo[4,5-c]quinolin-3(2H)-yl)ethyl)amino)-3-oxopropoxy)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Savitski MM, et al. Cell. 2018 Mar 22;173(1):260-274.e25.
molnova catalog
related products
-
Sirt2-PROTAC-1
A novel SirReal-based PROTAC that induces isotype-selective Sirt2 degradation (IC50=0.25 uM).
-
JH-XI-10-02
JH-XI-10-02 is a CDK8 PROTAC based on the CDK8 inhibitor JH-VIII-49, induces partial degradation of CDK8 in Jurkat cells with IC50 of 159 nM.
-
CCT-367766
CCT-367766 (CCT367766) is a novel heterobifunctional PROTAC that binds and degrades the putative transcription factor regulator Pirin in cells.
